Public-Private Consortium Jump-Starts COVID Treatment Access in Ten Countries
The Global Accountability Platform (COVID GAP) blog series. September 15, 2022 By Nellie Bristol Ten countries in sub-Saharan Africa and Southeast Asia will partner with a new public-private collaboration to scale up COVID-19 test and treat operations for high risk populations, the COVID Treatment Quick Start Consortium announced September 7. Working with an initial donation of 100,000 doses of Paxlovid from Pfizer, the consortium aims to integrate the program into long term systems that will offer a range of antivirals, including generic versions as they become available. When administered within five days of symptom onset, Paxlovid has been shown to significantly reduce hospitalization rates and deaths from COVID among patients 65 and older, regardless of vaccine status or prior infection. Older individuals, along with health workers, the immunocompromised, and those…